ABT vs ALG · P/E 25, rev $44.33B vs P/E 23, rev $1.63B
Abbott Laboratories (ABT) versus Alamo Group Inc (ALG) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Alamo Group Inc (ALG) is a farm & heavy construction machinery company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported ALG revenue for 2024-12-31 was $1.63B. Net income was $115.9M. Revenue was down 3.6% from 2023-12-31 to 2024-12-31. ALG currently screens at market cap $2.72B and trailing P/E 23.3.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. ALG currently screens at market cap $2.72B and trailing P/E 23.3.
Not investment advice. Open the ABT and ALG stock pages for the full models.
Not investment advice.